Gilead Sciences Inc (GILD)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data for Gilead Sciences Inc, the days of sales outstanding (DSO) ratio is not available or provided for the specified period. DSO is a financial metric that measures how long it takes a company to collect revenues after a sale has been made. It is calculated by dividing accounts receivable by average daily sales.
Without the actual DSO values for Gilead Sciences Inc for the mentioned time periods, it is not possible to analyze the company's efficiency in collecting its accounts receivable or to assess its liquidity position based on this particular ratio. It is essential to have access to the DSO figures to evaluate the company's effectiveness in managing its accounts receivable and to gauge the impact on its cash flow and working capital management.
Therefore, it is recommended to obtain the specific DSO values for Gilead Sciences Inc in order to conduct a more detailed and meaningful analysis of the company's receivables management and overall financial performance.
Peer comparison
Dec 31, 2024
See also:
Gilead Sciences Inc Average Receivable Collection Period (Quarterly Data)